
![]() |
|||||||||||||
WJPR Citation Report
|
| All | Since 2021 | |
| Citation | 9186 | 4781 |
| h-index | 32 | 25 |
| i10-index | 256 | 108 |
EMPHYSEMATOUS CYSTITIS: YET ANOTHER LETHAL OUTCOME FOLLOWING REPEATED ADMINISTRATION OF SGLT2 INHIBITOR
Austin Jasniewski and Udaya M Kabadi
. Abstract Emphysematous cystitis is a rare complication of urinary tract infection characterized by gas in the lumen and/or the wall of the bladder.[1] Risk factors include female sex, diabetes, neurogenic bladder, bladder outlet obstruction, and recurrent UTI.[1] Herein we describe a patient with Diabetes Mellitus who succumbed to septic shock induced by emphysematous cystitis following continued administration of SGLT 2 inhibitor despite multiple recurrent episodes of urinary tract infection. Keywords: . [Full Text Article] [Download Certificate] |
